Annual accounts receivable:
$11.01B+$1.92B(+21.07%)Summary
- As of today (June 22, 2025), LLY annual accounts receivable is $11.01 billion, with the most recent change of +$1.92 billion (+21.07%) on December 31, 2024.
- During the last 3 years, LLY annual accounts receivable has risen by +$4.33 billion (+64.93%).
- LLY annual accounts receivable is now at all-time high.
Performance
LLY Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$12.04B+$1.03B(+9.37%)Summary
- As of today (June 22, 2025), LLY quarterly accounts receivable is $12.04 billion, with the most recent change of +$1.03 billion (+9.37%) on March 31, 2025.
- Over the past year, LLY quarterly accounts receivable has increased by +$4.15 billion (+52.64%).
- LLY quarterly accounts receivable is now at all-time high.
Performance
LLY Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
LLY Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +52.6% |
| 3 y3 years | +64.9% | +90.4% |
| 5 y5 years | +142.0% | +135.7% |
LLY Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.9% | at high | +90.4% |
| 5 y | 5-year | at high | +142.0% | at high | +149.3% |
| alltime | all time | at high | +682.7% | at high | +758.2% |
LLY Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $12.04B(+9.4%) |
| Dec 2024 | $11.01B(+21.1%) | $11.01B(+6.9%) |
| Sep 2024 | - | $10.29B(-6.6%) |
| Jun 2024 | - | $11.03B(+39.8%) |
| Mar 2024 | - | $7.89B(-13.3%) |
| Dec 2023 | $9.09B(+31.8%) | $9.09B(+11.3%) |
| Sep 2023 | - | $8.17B(+8.7%) |
| Jun 2023 | - | $7.52B(-0.1%) |
| Mar 2023 | - | $7.53B(+9.1%) |
| Dec 2022 | $6.90B(+3.3%) | $6.90B(+2.7%) |
| Sep 2022 | - | $6.72B(+5.5%) |
| Jun 2022 | - | $6.36B(+0.7%) |
| Mar 2022 | - | $6.32B(-5.2%) |
| Dec 2021 | $6.67B(+13.6%) | $6.67B(+12.8%) |
| Sep 2021 | - | $5.91B(+1.5%) |
| Jun 2021 | - | $5.83B(+4.2%) |
| Mar 2021 | - | $5.59B(-4.8%) |
| Dec 2020 | $5.88B(+29.2%) | $5.88B(+20.2%) |
| Sep 2020 | - | $4.89B(+1.2%) |
| Jun 2020 | - | $4.83B(-5.4%) |
| Mar 2020 | - | $5.11B(+12.3%) |
| Dec 2019 | $4.55B(-1.0%) | $4.55B(+2.4%) |
| Sep 2019 | - | $4.44B(-3.7%) |
| Jun 2019 | - | $4.61B(+9.8%) |
| Mar 2019 | - | $4.20B(-8.6%) |
| Dec 2018 | $4.59B(+1.0%) | $4.59B(-5.5%) |
| Sep 2018 | - | $4.86B(+0.8%) |
| Jun 2018 | - | $4.82B(+7.3%) |
| Mar 2018 | - | $4.50B(-1.1%) |
| Dec 2017 | $4.55B(+12.8%) | $4.55B(+3.3%) |
| Sep 2017 | - | $4.40B(+1.2%) |
| Jun 2017 | - | $4.35B(+8.3%) |
| Mar 2017 | - | $4.02B(-0.3%) |
| Dec 2016 | $4.03B(+14.7%) | $4.03B(+4.7%) |
| Sep 2016 | - | $3.85B(-2.5%) |
| Jun 2016 | - | $3.95B(+9.0%) |
| Mar 2016 | - | $3.62B(+3.1%) |
| Dec 2015 | $3.51B(+8.6%) | $3.51B(+3.3%) |
| Sep 2015 | - | $3.40B(+1.6%) |
| Jun 2015 | - | $3.35B(+6.6%) |
| Mar 2015 | - | $3.14B(-2.8%) |
| Dec 2014 | $3.23B(-5.8%) | $3.23B(+5.9%) |
| Sep 2014 | - | $3.05B(-4.2%) |
| Jun 2014 | - | $3.19B(+6.2%) |
| Mar 2014 | - | $3.00B(-12.6%) |
| Dec 2013 | $3.43B(+2.9%) | $3.43B(-0.3%) |
| Sep 2013 | - | $3.44B(-3.7%) |
| Jun 2013 | - | $3.58B(+4.1%) |
| Mar 2013 | - | $3.44B(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $3.34B(-7.3%) | $3.34B(+2.1%) |
| Sep 2012 | - | $3.27B(+2.7%) |
| Jun 2012 | - | $3.18B(-6.5%) |
| Mar 2012 | - | $3.40B(-5.4%) |
| Dec 2011 | $3.60B(+3.0%) | $3.60B(+1.8%) |
| Sep 2011 | - | $3.53B(-7.8%) |
| Jun 2011 | - | $3.83B(+3.8%) |
| Mar 2011 | - | $3.69B(+5.7%) |
| Dec 2010 | $3.49B(+4.5%) | $3.49B(+14.0%) |
| Jun 2010 | - | $3.07B(-4.0%) |
| Mar 2010 | - | $3.19B(-4.5%) |
| Dec 2009 | $3.34B(+20.3%) | $3.34B(+10.8%) |
| Sep 2009 | - | $3.02B(+6.2%) |
| Jun 2009 | - | $2.84B(+6.2%) |
| Mar 2009 | - | $2.68B(-3.7%) |
| Dec 2008 | $2.78B(+3.9%) | $2.78B(+2.8%) |
| Sep 2008 | - | $2.70B(-1.4%) |
| Jun 2008 | - | $2.74B(+2.9%) |
| Mar 2008 | - | $2.66B(-0.5%) |
| Dec 2007 | $2.67B(+16.3%) | $2.67B(+6.3%) |
| Sep 2007 | - | $2.52B(+4.2%) |
| Jun 2007 | - | $2.41B(+7.1%) |
| Mar 2007 | - | $2.25B(-1.9%) |
| Dec 2006 | $2.30B(-0.6%) | $2.30B(+10.6%) |
| Sep 2006 | - | $2.08B(-1.1%) |
| Jun 2006 | - | $2.10B(-0.6%) |
| Mar 2006 | - | $2.11B(-8.6%) |
| Dec 2005 | $2.31B(+12.4%) | $2.31B(+12.4%) |
| Sep 2005 | - | $2.06B(-1.3%) |
| Jun 2005 | - | $2.09B(-1.3%) |
| Mar 2005 | - | $2.11B(+2.6%) |
| Dec 2004 | $2.06B(+10.4%) | $2.06B(+7.6%) |
| Sep 2004 | - | $1.91B(-3.1%) |
| Jun 2004 | - | $1.97B(+3.2%) |
| Mar 2004 | - | $1.91B(+2.5%) |
| Dec 2003 | $1.86B(+11.7%) | $1.86B(+11.9%) |
| Sep 2003 | - | $1.67B(-1.1%) |
| Jun 2003 | - | $1.68B(+1.7%) |
| Mar 2003 | - | $1.66B(-0.9%) |
| Dec 2002 | $1.67B(+18.8%) | $1.67B(+9.5%) |
| Sep 2002 | - | $1.53B(-7.8%) |
| Jun 2002 | - | $1.66B(+10.4%) |
| Mar 2002 | - | $1.50B(+6.6%) |
| Dec 2001 | $1.41B(-28.5%) | $1.41B(+0.3%) |
| Sep 2001 | - | $1.40B(-7.8%) |
| Jun 2001 | - | $1.52B(+3.4%) |
| Mar 2001 | - | $1.47B(-25.2%) |
| Dec 2000 | $1.97B(+6.7%) | $1.97B(+6.7%) |
| Dec 1999 | $1.84B(+6.1%) | $1.84B(+6.1%) |
| Dec 1996 | $1.74B | $1.74B |
FAQ
- What is Eli Lilly and Company annual accounts receivable?
- What is the all time high annual accounts receivable for Eli Lilly and Company?
- What is Eli Lilly and Company annual accounts receivable year-on-year change?
- What is Eli Lilly and Company quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly accounts receivable year-on-year change?
What is Eli Lilly and Company annual accounts receivable?
The current annual accounts receivable of LLY is $11.01B
What is the all time high annual accounts receivable for Eli Lilly and Company?
Eli Lilly and Company all-time high annual accounts receivable is $11.01B
What is Eli Lilly and Company annual accounts receivable year-on-year change?
Over the past year, LLY annual accounts receivable has changed by +$1.92B (+21.07%)
What is Eli Lilly and Company quarterly accounts receivable?
The current quarterly accounts receivable of LLY is $12.04B
What is the all time high quarterly accounts receivable for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly accounts receivable is $12.04B
What is Eli Lilly and Company quarterly accounts receivable year-on-year change?
Over the past year, LLY quarterly accounts receivable has changed by +$4.15B (+52.64%)